Relay Therapeutics is building clinical and commercial readiness, adding a VP of Clinical Operations and multiple senior directors across regulatory affairs, oncology R&D, and medical science liaison functions for APAC. The firm drew talent from Agios, AstraZeneca, Bicycle Therapeutics, Cytokinetics, and Daiichi Sankyo—all peers in oncology and rare disease. Operations emerged as the fastest-growing function, absorbing the majority of recent hires, while two entry-level contracts attorneys departed to Watts Water Technologies. Net movement: +7, signaling a shift toward later-stage development and geographic expansion.
Hires, exits and promotions across Relay Therapeutics and its rivals — every Monday. Drop your email, no account needed.
One short email a week. Unsubscribe anytime.
New hires per month, last 12 months. 13 total hires.
Hires, exits and promotions over the last 90 days — by role and function.
Sign up to Inkling to access all data.
Unlock with Inkling →Net change by function, last 90 days.
No elevated cluster of senior exit signals right now. Inkling flags one when it appears — track this market.
Which companies Relay Therapeutics hires from — and loses people to — over the last 90 days.
Inkling watches the people at every company you compete with and briefs you weekly
— the hire before the launch, the exit before it shows on their profile.
Aggregate signals refresh weekly. Moves are drawn from public profiles and reported by role — we never name individuals on this page.